Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a
disease of the human immune system caused by the human immunodeficiency virus (HIV).
This condition progressively reduces the effectiveness of the immune system and leaves
individuals susceptible to opportunistic infections and tumors. HIV is transmitted through
direct contact of a mucous membrane or the bloodstream with a bodily fluid containing HIV,
such as blood, semen, vaginal fluid, preseminal fluid, and breast milk.
Download PDF
References
- Alimonti JB, Ball TB, Fowke KR (2003). 'Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.'. J. Gen. Virol. 84 (7): 1649–1661. doi:10.1099/vir.0.19110-0. PMID 12810858.
- Bentwich Z, Kalinkovich, A, Weisman Z (1995). 'Immune activation is a dominant factor in the pathogenesis of African AIDS.'. Immunol. Today 16 (4): 187–191. PMID 7734046.
- Campbell GR, Pasquier E, Watkins J, et al. (2004). 'The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis'. J. Biol. Chem. 279 (46): 48197– 48204. doi:10.1074/jbc.M406195200. PMID 15331610.
- Epstein, Helen (2007). The invisible cure: Africa, the West, and the fight against AIDS. New York: Farrar, Straus, and Giroux. ISBN 0-374-28152-1.
- Grant I, Sacktor H, McArthur J (2005). 'HIV neurocognitive disorders'. in H. E. Gendelman, I. Grant, I. Everall, S. A. Lipton, and S. Swindells. (ed.) (PDF). The Neurology of AIDS (2nd ed.). London, UK: Oxford University Press. pp. 357–373. ISBN 0- 19-852610-5
- Koenig MA, Zablotska I, Lutalo T, Nalugoda F, Wagman J, Gray R (2004). 'Coerced first intercourse and reproductive health among adolescent women in Rakai, Uganda'. Int Fam Plan Perspect 30 (4): 156–63. doi:10.1363/ifpp.30.156.04. PMID 15590381.
- Lavreys L, Baeten JM, Martin HL, et al. (March 2004). 'Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study'. AIDS 18 (4): 695– 7. PMID 15090778.
- Mastro TD, de Vincenzi I (1996). 'Probabilities of sexual HIV-1 transmission'. AIDS 10 (Suppl A): S75–S82. PMID 8883613.
- Sagar M, Lavreys L, Baeten JM, et al. (2004). 'Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population'. AIDS 18 (4): 615–619. PMID 15090766.
- Tovanabutra S, Robison V, Wongtrakul J, et al. (2002). 'Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand'. J. Acquir. Immune. Defic. Syndr. 29 (3): 275–283. PMID 11873077.
- Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001). 'Neurological manifestations of HIV disease'. J. Assoc. Physicians India 49: 343–348. PMID 11291974.
- Yarchoan R, Tosatom G, Littlem RF (2005). 'Therapy insight: AIDS-related malignancies — the influence of antiviral therapy on pathogenesis and management'. Nat. Clin. Pract. Oncol. 2 (8): 406–415. doi:10.1038/ncponc0253. PMID 16130937.
Back
